
Currently out of the existing stock ratings of Christopher James, 50 are a BUY (80.65%), 11 are a SELL (17.74%), 1 are a HOLD (1.61%).
Analyst Christopher James, has had 52.4% of price targets met with an average potential upside of 47.77%, reached in 522 days on average. Previously, Christopher James worked at PIPER SANDLER, NOMURA, LADENBURG, RAYMOND JAMES, B. RILEY.
Christopher James has documented 124 price targets and ratings displayed on 13 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ALXN, Alexion Pharmaceuticals at 04-Feb-2021.
Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS).
The best stock recommendation documented was for ALNY (ALNYLAM PHARMACEUTICALS) on 10/16/2018. The price target of $73 was fulfilled within 8 days with a profit of $9.91 (11.95%), with a performance score of 14.94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Nov-2019
$11
7 years 14 days ago
(07-Nov-2019)
0/2 (0%)
$11 (0.00%)
$5
$5
7 years 1 months 3 days ago
(18-Oct-2019)
0/4 (0%)
$5 (0.00%)
$2.5
$8
7 years 6 months 18 days ago
(03-May-2019)
0/2 (0%)
$2.5 (0.00%)
$3.5
$4
8 years 9 months 13 days ago
(08-Feb-2018)
0/4 (0%)
$3.5 (0.00%)
$650
$16
9 years 2 months 9 days ago
(12-Sep-2017)
0/2 (0%)
$650 (0.00%)